Drugs / 11-ketoandrostenedione
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05246865 | Oct 2021 → Dec 2022 | polycystic ovary syndrome | University of Birmingham | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 11-ketoandrostenedione | “On Visits 2 and 3, participants will be administered either the classic androgen pathway precursor dehydroepiandrosterone or the 11-oxygenated androgen pathway precursor...” NCT05246865 ↗ |
| Route | Oral | “oral androgen challenge with 11-ketoandrostenedione” NCT05246865 ↗ |